Barret, J.R., Tracy, D.K., & Giaroli, G. (2013). To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol., 23(10), 640-647.

Braam, W., Van Geijlswijk, I., Keijzer, H., Smits, M. G., Didden, R., & Curfs, L. M. (2010). Loss of response to melatonin treatment is associated with slow melatonin metabolism. Journal of Intellectual Disability Research, 54(6), 547-555.

Braam, W., & Smits, M. (2008). Melatonine voor slaapstoornissen bij kinderen. Praktische Pediatrie, 3.

van Geijlswijk, I.M. (2011). Melatonin in sleepless children. PhD thesis, Utrecht University.

Gunning, W.B. (2008). Slaapproblemen bij kinderen met ADHD. Psyfar, 10-15.

Hirota, T., Schwartz, S., & Correll, C. U. (2014). Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy. Journal of the American Academy of Child and Adolescent Psychiatry, 53(2), 153–173.

Jain, R., Segal, S., Kollins, S. H., & Khayrallah, M. (2011). Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 50(2), 171–179.

Karsten J, Hagenauw LA, Kamphuis J, Lancel M. Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial. J Psychopharmacol. 2017 Mar;31(3):327-337. doi: 10.1177/0269881116681399. Epub 2017 Jan 16. PMID: 28093029.

Mirtazapine, H19. slaapstoornissen in de psychiatrie, M. Lancel(red)

Posey, D. J., Guenin, K. D., Kohn, A. E., Swiezy, N. B., & McDougle, C. J. (2001). A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders. Journal of child and adolescent psychopharmacology, 11(3), 267–277.

Salanitro M, Wrigley T, Ghabra H, de Haan E, Hill CM, Solmi M, Cortese S. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2022 Aug;139:104723. doi: 10.1016/j.neubiorev.2022.104723. Epub 2022 Jun 9. PMID: 35691474.

Solleveld MM, Schrantee A, Baek HK, Bottelier MA, Tamminga HGH, Bouziane C, Stoffelsen R, Lucassen PJ, Van Someren EJW, Rijsman RM, Reneman L. Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD. Front Psychiatry. 2020 Feb 28;11:82. doi: 10.3389/fpsyt.2020.00082. PMID: 32184743; PMCID: PMC7058799.

Wilson, S. J., Nutt, D. J., Alford, C., Argyropoulos, S. V., Baldwin, D. S., Bateson, A. N., Britton, T. C., Crowe, C., Dijk, D. J., Espie, C. A., Gringras, P., Hajak, G., Idzikowski, C., Krystal, A. D., Nash, J. R., Selsick, H., Sharpley, A. L., & Wade, A. G. (2010). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. Journal of psychopharmacology (Oxford, England), 24(11), 1577–1601.

Wirojanan, J., Jacquemont, S., Diaz, R., Bacalman, S., Anders, T. F., Hagerman, R. J., & Goodlin-Jones, B. L. (2009). The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 5(2), 145–150.